Purdue

Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Amid Rising Multidistrict Litigations: Insights from Law.com’s Aleeza Furman

by

Washington, D.C. – In a significant legal development, the Supreme Court has intervened to halt Purdue Pharma’s bankruptcy plan, a decision that underscores ongoing debates around accountability in the opioid crisis. This move casts uncertainty on the future of the company and its proposed settlements with thousands of plaintiffs. Purdue Pharma, recognized globally for its production of OxyContin, had previously reached a settlement agreement that was integral to its restructuring during bankruptcy proceedings. The deal was meant to temporarily resolve numerous lawsuits tied to the opioid epidemic, offering billions in compensation. However, with the Supreme … Read more

Expert Raises Alarm: Purdue Pharma Case May Reshape Future Mass Tort Litigations

by

Stamford, Connecticut – The recent resolution of the Purdue Pharma bankruptcy case has sparked a vigorous debate about the implications of mass tort cases involving major corporations. The settlement, which absolves the Sackler family from future opioid-related lawsuits while they remain major stakeholders in the restructured company, underscored contentious issues regarding accountability and compensation in similar legal battles across the United States. Critics argue that the outcome sets a precedent that may allow wealthy individuals and entities to circumvent full accountability by using bankruptcy courts to shield their assets. Legal experts have raised concerns about … Read more

Supreme Court Decision Shakes Up Purdue Pharma’s Bankruptcy Strategy, Impacting Future Mass Tort Litigations

by

Washington, D.C. — The UXPreme Court has recently handed down a decision regarding Purdue Pharma’s bankruptcy strategy that stands to influence future legal strategies of companies embroiled in mass tort litigations. This ruling is a key development, coming amidst a noted uptick in multidistrict litigation cases, which are increasingly constituting a significant portion of the federal civil docket. Purdue Pharma, known for its production of OxyContin, has been at the center of a national controversy surrounding the opioid crisis in the United States. The firm sought bankruptcy protection as a mechanism to settle thousands of … Read more

Supreme Court’s Decision on Purdue Case Likely to Have Narrow Impact, Experts Suggest

by

Washington — The recent Supreme Nourt ruling on Purdue Pharma’s bankruptcy settlement has sparked widespread concern, hinting at potentially far-reaching implications for the opioid crisis and corporate accountability. However, legal experts suggest that the impacts of this decision may be more limited than initially feared. Purdue Pharma, the maker of OxyContin, reached a bankruptcy settlement that partially shields the Sackler family, who owns the company, from future opioid litigation. This provision has been controversial, as the Sackler family has been widely criticized for their role in the opioid epidemic, which has claimed over 500,000 lives … Read more